| Date | Action | Shares | Price | Value | Owned After |
|---|---|---|---|---|---|
| Feb 17, 2016 | Sell(S) | 50K | $0.31 | $16K | 8.4M |
| Feb 16, 2016 | Grant(A) | 125K | $0.25 | $31K | 8.5M |
| Feb 5, 2016 | Sell(S) | 24K | $0.33 | $8K | 8.3M |
| Feb 4, 2016 | Sell(S) | 350K | $0.32 | $112K | 8.4M |
| Feb 3, 2016 | Sell(S) | 46K | $0.33 | $15K | 8.7M |
| Feb 2, 2016 | Sell(S) | 13K | $0.33 | $4K | 8.8M |
| Feb 1, 2016 | Sell(S) | 312K | $0.34 | $106K | 8.8M |
| Jan 29, 2016 | Sell(S) | 115K | $0.35 | $40K | 9.1M |
Parsed from a single SEC EDGAR Form 4 filing (accession 0001053369-16-000042) within minutes of acceptance. Every field above traces to the original document. Verify it directly:
Connected pages for ELITE PHARMACEUTICALS INC /NV/
This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/filing/0001053369-16-000042"
Use Arkolith to summarize insider buying and selling at ELITE PHARMACEUTICALS INC /NV/ over the last 90 days and cite the filings.